RNA Vaccines
Springer New York
Chapter title |
Nonclinical Safety Testing of RNA Vaccines.
|
---|---|
Chapter number | 16 |
Book title |
RNA Vaccines
|
Published in |
Methods in molecular biology, January 2017
|
DOI | 10.1007/978-1-4939-6481-9_16 |
Pubmed ID | |
Book ISBNs |
978-1-4939-6479-6, 978-1-4939-6481-9
|
Authors |
Gundel Hager, Hager, Gundel |
Editors |
Thomas Kramps, Knut Elbers |
Abstract |
In this chapter, we first consider the overall goal of nonclinical safety testing during drug development and have a brief overview of its regulatory background. We then discuss some basic requirements of safety/toxicity testing before concentrating on the safety testing of RNA vaccines and developing a sample RNA vaccine safety testing program. |
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 29% |
Student > Ph. D. Student | 1 | 14% |
Student > Bachelor | 1 | 14% |
Student > Master | 1 | 14% |
Unknown | 2 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 14% |
Biochemistry, Genetics and Molecular Biology | 1 | 14% |
Immunology and Microbiology | 1 | 14% |
Materials Science | 1 | 14% |
Unknown | 3 | 43% |